In multivariate analysis both the PD-L1 combined biomarker and the Gal-9 combined biomarker, together with AFP > 100 μgl−1 and cirrhosis, are independent predictors of HCC-specific survival (Table 2). The gene discussed is CD274; the disease is hepatocellular carcinoma.